Thus, it remains unclear whether CD69+CD103+T cells are true TRM cells or alternately the expression of these molecules identifies effector T-cell subsets that have infiltrated the tumor bed where abundant TGF-β found in a large quantity in many tumors drives CD103 expression. The gene discussed is ITGAE; the disease is neoplasm.